Jim Simons Altamira Therapeutics Ltd. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.27 - $120.04 $5,385 - $2.39 Million
19,946 New
19,946 $6,000
Q4 2021

Feb 11, 2022
SELL
$1.28 - $2.4 $91,169 - $170,942
-71,226 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$2.01 - $3.58 $143,164 - $254,989
71,226 New
71,226 $143,000

About Altamira Therapeutics Ltd.

CYTO Quotes by TradingView
  • Ticker CYTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,009,710
  • Market Cap $172K
  • Description
  • Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...
More about CYTO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email